Jakobi Arjen-Joachim, Mauser Harald, Clark Timothy
Discovery Chemistry, F. Hoffmann-La Roche AG, 4070, Basel, Switzerland.
J Mol Model. 2008 Jul;14(7):547-58. doi: 10.1007/s00894-008-0302-3. Epub 2008 May 1.
A frequent task in computer-aided drug design is to identify novel chemotypes similar in activity but structurally different to a given reference structure. Here we report the development of a novel method for atom-independent similarity comparison of molecular fragments (substructures of drug-like molecules). The fragments are characterized by their local surface properties coded in the form of 3D pharmacophores. As surface properties, we used the electrostatic potential (MEP), the local ionization energy (IE(L)), local electron affinity (EA(L)) and local polarizability (POL) calculated on isodensity surfaces. A molecular fragment can then be represented by a minimal set of extremes for each surface property. We defined a tolerance sphere for each of these extremes, thus allowing us to assess the similarity of fragments in an analogous manner to classical pharmacophore comparison. As a first application of this method we focused on comparing rigid fragments suitable for scaffold hopping. A retrospective analysis of successful scaffold hopping reported for Factor Xa inhibitors [Wood MR et al (2006) J Med Chem 49:1231] showed that our method performs well where atom-based similarity metrics fail.
计算机辅助药物设计中的一项常见任务是识别与给定参考结构活性相似但结构不同的新型化学类型。在此,我们报告了一种用于分子片段(类药物分子的子结构)的与原子无关的相似性比较的新方法。这些片段通过以三维药效团形式编码的局部表面性质来表征。作为表面性质,我们使用了在等密度表面上计算的静电势(MEP)、局部电离能(IE(L))、局部电子亲和能(EA(L))和局部极化率(POL)。然后,一个分子片段可以由每个表面性质的一组最小极值来表示。我们为这些极值中的每一个定义了一个容差球,从而使我们能够以类似于经典药效团比较的方式评估片段的相似性。作为该方法的首次应用,我们专注于比较适用于骨架跃迁的刚性片段。对已报道的凝血因子Xa抑制剂的成功骨架跃迁进行的回顾性分析[Wood MR等人(2006年)《药物化学杂志》49:1231]表明,在基于原子的相似性度量失败的情况下,我们的方法表现良好。